BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 19555584)

  • 1. NCCN clinical practice guidelines in oncology: kidney cancer.
    Motzer RJ; Agarwal N; Beard C; Bolger GB; Boston B; Carducci MA; Choueiri TK; Figlin RA; Fishman M; Hancock SL; Hudes GR; Jonasch E; Kessinger A; Kuzel TM; Lange PH; Levine EG; Margolin KA; Michaelson MD; Olencki T; Pili R; Redman BG; Robertson CN; Schwartz LH; Sheinfeld J; Wang J
    J Natl Compr Canc Netw; 2009 Jun; 7(6):618-30. PubMed ID: 19555584
    [No Abstract]   [Full Text] [Related]  

  • 2. Kidney cancer. Clinical practice guidelines in oncology.
    Motzer RJ; Bolger GB; Boston B; Carducci MA; Fishman M; Hancock SL; Hauke RJ; Hudes GR; Jonasch E; Kantoff P; Kuzel TM; Lange PH; Levine EG; Logothetis C; Margolin KA; Pohar K; Redman BG; Robertson CN; Samlowski WE; Sheinfeld J;
    J Natl Compr Canc Netw; 2006 Nov; 4(10):1072-81. PubMed ID: 17112454
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Escudier B; Kataja V;
    Ann Oncol; 2010 May; 21 Suppl 5():v137-9. PubMed ID: 20555064
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
    Escudier B; Porta C; Schmidinger M; Rioux-Leclercq N; Bex A; Khoo V; Grünwald V; Gillessen S; Horwich A;
    Ann Oncol; 2019 May; 30(5):706-720. PubMed ID: 30788497
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal cell carcinoma: what the surgeon and treating physician need to know.
    Chapin BF; Delacroix SE; Wood CG
    AJR Am J Roentgenol; 2011 Jun; 196(6):1255-62. PubMed ID: 21606286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Escudier B; Eisen T; Porta C; Patard JJ; Khoo V; Algaba F; Mulders P; Kataja V;
    Ann Oncol; 2012 Oct; 23 Suppl 7():vii65-71. PubMed ID: 22997456
    [No Abstract]   [Full Text] [Related]  

  • 7. New perspectives on the treatment of metastatic renal cell carcinoma: an introduction and historical overview.
    Motzer RJ
    Oncologist; 2011; 16 Suppl 2(Suppl 2):1-3. PubMed ID: 21346034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Escudier B; Porta C; Schmidinger M; Algaba F; Patard JJ; Khoo V; Eisen T; Horwich A;
    Ann Oncol; 2014 Sep; 25 Suppl 3():iii49-56. PubMed ID: 25210086
    [No Abstract]   [Full Text] [Related]  

  • 9. [Not Available].
    Aktuelle Urol; 2015 Nov; 46(6):430. PubMed ID: 26599942
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Escudier B; Porta C; Schmidinger M; Rioux-Leclercq N; Bex A; Khoo V; Gruenvald V; Horwich A;
    Ann Oncol; 2016 Sep; 27(suppl 5):v58-v68. PubMed ID: 27664262
    [No Abstract]   [Full Text] [Related]  

  • 11. Integrative tumor board: metastatic renal cell carcinoma: medical oncology.
    Gupta SK; Vogelzang N
    Integr Cancer Ther; 2004 Mar; 3(1):26-9. PubMed ID: 15035871
    [No Abstract]   [Full Text] [Related]  

  • 12. [Multimodal interventional therapy of a large renal cell carcinoma in a patient with high anesthesia risk - a case report].
    Brinkhaus G; Wust P; Gebauer B
    Rofo; 2011 Mar; 183(3):286-8. PubMed ID: 21113871
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeted therapy for locally advanced renal cell carcinoma.
    Jonasch E; Tannir NM
    Target Oncol; 2010 Jun; 5(2):113-8. PubMed ID: 20625844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary management of advanced renal cell carcinoma.
    Khanna A; Crane A; Yerram N; Sun D; Ericson K; Lundy SD; Abouassaly R
    Clin Adv Hematol Oncol; 2018 Jun; 16(6):438-446. PubMed ID: 30067615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Are immunotherapy and chemotherapy in metastatic renal cell cancer out?].
    Schmitz-Dräger BJ
    Urologe A; 1992 Jul; 31(4):213-4. PubMed ID: 1514204
    [No Abstract]   [Full Text] [Related]  

  • 16. Managing the complex journey of renal cell carcinoma.
    Amen K
    ONS Connect; 2007; 22(8 Suppl):53-4. PubMed ID: 17824565
    [No Abstract]   [Full Text] [Related]  

  • 17. 50 Years Ago in TheJournal ofPediatrics: 50 years of progress in renal cell carcinoma: From case reports to targeted therapy.
    Campbell K; Mullen E
    J Pediatr; 2020 Mar; 218():120. PubMed ID: 32089177
    [No Abstract]   [Full Text] [Related]  

  • 18. [Renal cell cancer].
    Németh I; Iványi B; Pajor L
    Orv Hetil; 2006 Jul; 147(28):1336-7. PubMed ID: 16999021
    [No Abstract]   [Full Text] [Related]  

  • 19. NCCN practice guidelines for kidney cancer. National Comprehensive Cancer Network.
    Oncology (Williston Park); 1998 Nov; 12(11A):396-412. PubMed ID: 10028523
    [No Abstract]   [Full Text] [Related]  

  • 20. [Update uro-oncology: scientific meetings 2011].
    Hegele A; Skrobek L; Schrader AJ
    Aktuelle Urol; 2012 Jan; 43(1):13-27. PubMed ID: 22344822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.